Autophagy proteins in prostate cancer: Relation with anaerobic metabolism and Gleason score

作者：Giatromanolaki Alexandra^*; Sivridis Efthimios; Mendrinos Savvas; Koutsopoulos Anastasios V; Koukourakis Michael I

来源：Urologic Oncology-Seminars and Original Investigations, 2014, 32(1): 39.e11-39.e18.

DOI：10.1016/j.urolonc.2013.04.003

• Autophagy
• LC3A
• LC3B
• p62
• LDH5
• Prostate cancer

Objectives: Up-regulation of autophagy provides an important survival mechanism to normal and malignant cells residing in a hypoxic and unfavorable nutritional environment. Yet, its role in the biology of prostate cancer remains poorly understood.
Methods: In this study we investigated the expression of four major autophagy proteins, namely the microtubule-associated protein 1 light chain 3A (LC3A), LC3B. Beclin 1. and p62, together with an enzyme of anaerobic metabolism, the lactate dehydrogenase 5 (LDH5), in relation to Gleason score and extraprostatic invasion. A series of 96 prostate adenocarcinomas was examined using immunohistochemical techniques and appropriate antibodies.
Results: The LC3A protein was expressed in the form of "stone-like" structures, and diffuse cytoplasmic staining. the LC3B reactivity was solely cytoplasmic, whereas that of p62 and LDH5 was both cytoplasmic and nuclear. A median count of 0.90 "stone-like" structures per 200x optical field (range 0-3.6) was highly associated with a high Gleason score. Similarly, a strong cytoplasmic LC3A, LC3B, and p62 expression, when extensive (present in >50% tumor cells per section), was significantly associated with LDH5 and a high Gleason score. In addition, extensive cytoplasmic p62 expression was related with LC3A and B reactivity and also with extraprostatic invasion. Extensive Beclin-1 expression was significantly linked with extraprostatic invasion and also with p62 and LDH5 expression.
Conclusions: Immunohistochemical detection of autophagy proteins may potentially prove to be useful as prognostic markers and a tool for the stratification of patients in therapeutic trials targeting autophagy in prostate cancer.

• 出版日期2014-1